Fig 1: Evaluation of expression of key Purkinje markers in control vs PURK-cocktail-treated cellsImmunocytochemistry and fluorescent microscopy showed that the control cells did not express key Purkinje markers [ETV1, IRX3, SCN5a, or PCP4] or the CRISPR-Cas9 Knock-in CNTN2-IRES-mCherry. In contrast, the PURK-cocktail-treated cells strongly expressed ETV1, IRX3, SCN5a, or PCP4 and the CRISPR-Cas9 Knock-in CNTN2-IRES-mCherry reporter gene. DAPI was used to stain the cells' nuclei. The scale bar corresponds to 100 µm in all pictures.
Supplier Page from OriGene Technologies for ER81 (ETV1) Human qPCR Primer Pair (NM_004956)